ZA946142B - Therapeutic heterocycles - Google Patents

Therapeutic heterocycles

Info

Publication number
ZA946142B
ZA946142B ZA946142A ZA946142A ZA946142B ZA 946142 B ZA946142 B ZA 946142B ZA 946142 A ZA946142 A ZA 946142A ZA 946142 A ZA946142 A ZA 946142A ZA 946142 B ZA946142 B ZA 946142B
Authority
ZA
South Africa
Prior art keywords
heterocycles
therapeutic heterocycles
therapeutic
implicated
receptor
Prior art date
Application number
ZA946142A
Other languages
English (en)
Inventor
Scott Carson Miller
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ZA946142B publication Critical patent/ZA946142B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA946142A 1993-08-17 1994-08-15 Therapeutic heterocycles ZA946142B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939317104A GB9317104D0 (en) 1993-08-17 1993-08-17 Therapeutic heterocycles

Publications (1)

Publication Number Publication Date
ZA946142B true ZA946142B (en) 1995-02-17

Family

ID=10740632

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946142A ZA946142B (en) 1993-08-17 1994-08-15 Therapeutic heterocycles

Country Status (24)

Country Link
US (6) US5567700A (ru)
EP (1) EP0714392B1 (ru)
JP (1) JP3502386B2 (ru)
KR (1) KR100359631B1 (ru)
CN (1) CN1077573C (ru)
AT (1) ATE172971T1 (ru)
AU (1) AU677091B2 (ru)
CA (1) CA2166800C (ru)
CZ (1) CZ285299B6 (ru)
DE (1) DE69414398T2 (ru)
DK (1) DK0714392T3 (ru)
ES (1) ES2123810T3 (ru)
FI (1) FI111253B (ru)
GB (2) GB9317104D0 (ru)
HU (1) HU219586B (ru)
IL (1) IL110672A (ru)
MY (1) MY112102A (ru)
NO (1) NO305657B1 (ru)
NZ (1) NZ269575A (ru)
PL (1) PL178426B1 (ru)
RU (1) RU2153498C2 (ru)
SK (1) SK281232B6 (ru)
WO (1) WO1995005377A1 (ru)
ZA (1) ZA946142B (ru)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583134A (en) * 1992-09-30 1996-12-10 Sanofi 1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present
GB9321557D0 (en) * 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
GB9322643D0 (en) * 1993-11-03 1993-12-22 Zeneca Ltd Lactam derivatives
US5589489A (en) * 1993-12-15 1996-12-31 Zeneca Limited Cyclic amide derivatives for treating asthma
GB9408872D0 (en) * 1994-05-03 1994-06-22 Zeneca Ltd Heterocyclic compounds
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
US5998444A (en) * 1995-10-24 1999-12-07 Zeneca Ltd. Piperidinyl compounds as NK1 or NK2 antagonists
EP0709375B1 (en) * 1994-10-25 2005-05-18 AstraZeneca AB Therapeutic heterocycles
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9421709D0 (en) * 1994-10-27 1994-12-14 Zeneca Ltd Therapeutic compounds
GB9508786D0 (en) * 1995-04-29 1995-06-21 Zeneca Ltd Substituted heterocycles
US5688960A (en) * 1995-05-02 1997-11-18 Schering Corporation Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
US5696267A (en) * 1995-05-02 1997-12-09 Schering Corporation Substituted oximes, hydrazones and olefins as neurokinin antagonists
GB9521781D0 (en) * 1995-10-24 1996-01-03 Merck Sharp & Dohme Therapeutic agents
GB9523526D0 (en) * 1995-11-17 1996-01-17 Zeneca Ltd Therapeutic compounds
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5789422A (en) * 1996-10-28 1998-08-04 Schering Corporation Substituted arylalkylamines as neurokinin antagonists
IL135408A0 (en) * 1997-11-21 2001-05-20 Schering Corp Substituted oximes as neurokinin antagonists
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
US6063926A (en) * 1998-11-18 2000-05-16 Schering Corporation Substituted oximes as neurokinin antagonists
CA2355886C (en) * 1998-12-23 2006-10-31 Schering Corporation Substituted oximes and hydrazones as neurokinin antagonists
US6204265B1 (en) 1998-12-23 2001-03-20 Schering Corporation Substituted oximes and hydrazones as neurokinin antagonists
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence
SE0103668D0 (sv) * 2001-11-02 2001-11-02 Astrazeneca Ab Method for the treatment of overactive blader
SE0103795D0 (sv) 2001-11-02 2001-11-02 Astrazeneca Ab Compounds and method for the treatment of överactive bladder
US20100189797A1 (en) 2002-06-10 2010-07-29 Julien Mendlewicz Oral antidepressant formulation
TW200508221A (en) 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
GB0326407D0 (en) * 2003-11-12 2003-12-17 Glaxo Group Ltd Chemical compounds
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
GB0412865D0 (en) * 2004-06-09 2004-07-14 Glaxo Group Ltd Chemical compounds
AR057828A1 (es) 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
US8106208B2 (en) * 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903957A1 (en) * 1989-11-06 1991-05-08 Sanofi Sa Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present
UA41251C2 (ru) * 1990-01-04 2001-09-17 Пфайзер, Інк. Гидрированные азотсодержащие гетероциклические соединения, производные пиперидина, фармацевтическая композиция и способ угнетения активности вещества р в организме
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676053B1 (fr) * 1991-05-03 1993-08-27 Sanofi Elf Nouveaux composes dialkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676781B1 (fr) * 1991-05-23 1995-03-31 Peugeot Dispositif de refroidissement de l'air de suralimentation d'un moteur a combustion interne d'un vehicule.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
GB9321557D0 (en) * 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
GB9325074D0 (en) * 1993-12-07 1994-02-02 Zeneca Ltd Bicyclic heterocycles

Also Published As

Publication number Publication date
EP0714392A1 (en) 1996-06-05
GB9317104D0 (en) 1993-09-29
ATE172971T1 (de) 1998-11-15
HU9503826D0 (en) 1996-02-28
HUT75113A (en) 1997-04-28
IL110672A (en) 1999-06-20
SK281232B6 (sk) 2001-01-18
GB9416442D0 (en) 1994-10-05
MY112102A (en) 2001-04-30
FI111253B (fi) 2003-06-30
ES2123810T3 (es) 1999-01-16
US5861392A (en) 1999-01-19
IL110672A0 (en) 1994-11-11
US6444809B1 (en) 2002-09-03
PL178426B1 (pl) 2000-04-28
NO960630D0 (no) 1996-02-16
CA2166800C (en) 2006-06-06
CZ285299B6 (cs) 1999-06-16
KR100359631B1 (ko) 2003-01-24
CN1129449A (zh) 1996-08-21
DE69414398T2 (de) 1999-05-06
JP3502386B2 (ja) 2004-03-02
SK21096A3 (en) 1997-02-05
US20030187255A1 (en) 2003-10-02
US5567700A (en) 1996-10-22
EP0714392B1 (en) 1998-11-04
CA2166800A1 (en) 1995-02-23
JPH09501439A (ja) 1997-02-10
AU7388094A (en) 1995-03-14
NO960630L (no) 1996-02-16
AU677091B2 (en) 1997-04-10
FI960727A0 (fi) 1996-02-16
CN1077573C (zh) 2002-01-09
US5990130A (en) 1999-11-23
US6124279A (en) 2000-09-26
DE69414398D1 (de) 1998-12-10
DK0714392T3 (da) 2001-02-05
NO305657B1 (no) 1999-07-05
RU2153498C2 (ru) 2000-07-27
US7053213B2 (en) 2006-05-30
WO1995005377A1 (en) 1995-02-23
PL313075A1 (en) 1996-05-27
HU219586B (hu) 2001-05-28
NZ269575A (en) 1997-11-24
CZ43496A3 (en) 1996-05-15
FI960727A (fi) 1996-02-16

Similar Documents

Publication Publication Date Title
ZA946142B (en) Therapeutic heterocycles
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
IL119462A (en) 1-trimethylphenyl-3-substituted 1H-pyrrol-2-amines
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
IL98163A0 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides,pharmaceuticals containing these compounds and their use
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
ID28003A (id) Turunan-turunan adamantana
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
HK1028594A1 (en) Adamantane derivatives
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
SE9704546D0 (sv) Novel compounds
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
AU9064991A (en) Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
MX9708557A (es) Nuevo uso farmacologico de los antagonistas del receptor aii.
ZA929879B (en) Compositions for the treatment of mammalian diseases.
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
AP9600780A0 (en) Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.
MX9710002A (es) Nuevo uso medico.
AU4123297A (en) Alkaloid glycoside for use as a medicament